These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36448553)

  • 1. Elucidating the function of hypothetical PE_PGRS45 protein of
    Medha ; Joshi H; Sharma S; Sharma M
    J Biomol Struct Dyn; 2023 Nov; 41(19):10009-10025. PubMed ID: 36448553
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycobacterium tuberculosis PE_PGRS45 (Rv2615c) Promotes Recombinant Mycobacteria Intracellular Survival via Regulation of Innate Immunity, and Inhibition of Cell Apoptosis.
    Xu T; Wang C; Li M; Wei J; He Z; Qian Z; Wang X; Wang H
    J Microbiol; 2024 Jan; 62(1):49-62. PubMed ID: 38337112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of mechanism of interaction of truncated isoniazid-nicotinamide adenine dinucleotide adduct against multiple enzymes of Mycobacterium tuberculosis by a computational approach.
    Jena L; Deshmukh S; Waghmare P; Kumar S; Harinath BC
    Int J Mycobacteriol; 2015 Dec; 4(4):276-83. PubMed ID: 26964808
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Jagadeb M; Rath SN; Sonawane A
    J Biomol Struct Dyn; 2019 Aug; 37(13):3388-3398. PubMed ID: 30132739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
    Oliveira JS; Pereira JH; Canduri F; Rodrigues NC; de Souza ON; de Azevedo WF; Basso LA; Santos DS
    J Mol Biol; 2006 Jun; 359(3):646-66. PubMed ID: 16647717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Codon Optimization, Soluble Expression and Purification of PE_PGRS45 Gene from
    Xu T; Li M; Wang C; Yuan M; Chang X; Qian Z; Li B; Sun M; Wang H
    J Microbiol Biotechnol; 2021 Nov; 31(11):1583-1590. PubMed ID: 34489370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis.
    Unissa AN; Subbian S; Hanna LE; Selvakumar N
    Infect Genet Evol; 2016 Nov; 45():474-492. PubMed ID: 27612406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A virtual screen discovers novel, fragment-sized inhibitors of Mycobacterium tuberculosis InhA.
    Perryman AL; Yu W; Wang X; Ekins S; Forli S; Li SG; Freundlich JS; Tonge PJ; Olson AJ
    J Chem Inf Model; 2015 Mar; 55(3):645-59. PubMed ID: 25636146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid derivatives and their anti-tubercular activity.
    Hu YQ; Zhang S; Zhao F; Gao C; Feng LS; Lv ZS; Xu Z; Wu X
    Eur J Med Chem; 2017 Jun; 133():255-267. PubMed ID: 28390957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow-onset inhibition of 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis by an inorganic complex.
    Oliveira JS; de Sousa EH; de Souza ON; Moreira IS; Santos DS; Basso LA
    Curr Pharm Des; 2006; 12(19):2409-24. PubMed ID: 16842188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of the synergistic activity of ethambutol and isoniazid against
    Zhu C; Liu Y; Hu L; Yang M; He ZG
    J Biol Chem; 2018 Oct; 293(43):16741-16750. PubMed ID: 30185616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium tuberculosis dihydrofolate reductase is not a target relevant to the antitubercular activity of isoniazid.
    Wang F; Jain P; Gulten G; Liu Z; Feng Y; Ganesula K; Motiwala AS; Ioerger TR; Alland D; Vilchèze C; Jacobs WR; Sacchettini JC
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3776-82. PubMed ID: 20566771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Dynamics Assisted Mechanistic Insight of Val430-Ala Mutation of Rv1592c Protein in Isoniazid Resistant
    Kumar A; Anand PK; Chandel S; Shrivatava A; Kaur J
    Curr Comput Aided Drug Des; 2021; 17(1):95-106. PubMed ID: 31939732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
    Dias MV; Vasconcelos IB; Prado AM; Fadel V; Basso LA; de Azevedo WF; Santos DS
    J Struct Biol; 2007 Sep; 159(3):369-80. PubMed ID: 17588773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PE_PGRS45 (Rv2615c) protein of Mycobacterium tuberculosis perturbs mitochondria of macrophages.
    Medha ; Priyanka ; Sharma S; Sharma M
    Immunol Cell Biol; 2023 Aug; ():. PubMed ID: 37565603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational changes in 2-trans-enoyl-ACP (CoA) reductase (InhA) from M. tuberculosis induced by an inorganic complex: a molecular dynamics simulation study.
    da Costa AL; Pauli I; Dorn M; Schroeder EK; Zhan CG; de Souza ON
    J Mol Model; 2012 May; 18(5):1779-90. PubMed ID: 21833828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid.
    Unissa AN; Doss C GP; Kumar T; Swathi S; Lakshmi AR; Hanna LE
    J Glob Antimicrob Resist; 2017 Dec; 11():57-67. PubMed ID: 28743650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multidrug efflux protein in Mycobacterium tuberculosis; tap as a potential drug target for drug repurposing.
    Dwivedi M; Mukhopadhyay S; Yadav S; Dubey KD
    Comput Biol Med; 2022 Jul; 146():105607. PubMed ID: 35617724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoniazid Derivatives as Anti-Tubercular Agents: From Structural Design to Clinical Investigations.
    Ridahunlang N; Bisht R; Rishanlang N
    Infect Disord Drug Targets; 2023; 23(3):e041022209552. PubMed ID: 36200205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.
    Slayden RA; Lee RE; Barry CE
    Mol Microbiol; 2000 Nov; 38(3):514-25. PubMed ID: 11069675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.